Company Overview
Snapshot
Founded in December 2023 by Shahar Karny, Eran Small, and Yoram Cohen, PhenoTA operates with 1–10 employees. The company has secured funding across one round from two investors. In January 2024, PhenoTA raised a Seed round from Jibe Ventures.
Business overview
PhenoTA is a Health Tech & Life Sciences company focused on transforming medical decision-making through advanced blood test analysis. The company develops novel technology and applies artificial intelligence capabilities to blood cells, aiming to provide comprehensive health insights from routine blood tests. PhenoTA operates in the Medical Devices sector, targeting the Healthcare & Life Sciences market, specifically healthcare providers, with a B2B business model.
Log in to access full profile ›Company Intelligence Q&A
- When was PhenoTA founded?
- PhenoTA was founded in December 2023.
- Who are the founders of PhenoTA?
- The co-founders of PhenoTA are Shahar Karny, Eran Small, and Yoram Cohen.
- What is PhenoTA's primary sector?
- PhenoTA's primary sector is Health Tech & Life Sciences, with a focus on Medical Devices.
- What is PhenoTA's core technology?
- PhenoTA leverages Artificial Intelligence to analyze blood cells for advanced health insights.